No more 'death sentence': 100% survival rate achieved in gene therapy trial
All patients showed adequate levels of the CD18 protein needed to fight infections in the long term.
Five of the children who received treatment in a gene therapy clinical trial co-led by UCLA.(photo credit: UCLA Broad Stem Cell Research Center/Great Ormond Street Hospital)
